Polysaccharide and methods
OwnerJohn McGiven, Laurence Howells +4inventors
InventorsJohn McGiven, Laurence Howells, Lucy Duncombe, David Bundle, Satadru Sekhar Mandal, Susmita Sarkar
Life of this patent
Estimating the term…
Loading patent…
OwnerJohn McGiven, Laurence Howells +4inventors
InventorsJohn McGiven, Laurence Howells, Lucy Duncombe, David Bundle, Satadru Sekhar Mandal, Susmita Sarkar
Estimating the term…
There is provided a molecule comprising a chain of seven or more contiguous units of 4,6-dideoxy-4-acylamido-α-pyranose, each pair of units joined by a C1-C2 or a C1-C3 link, the chain having a terminal end and a reducing end, wherein the pyranose ring in the unit of the chain most distal from the reducing end is linked to a cap structure. The cap structure is not a 4,6-dideoxy-4-acylamido-α-pyranose. There are also provided vaccine compositions comprising the molecule and methods of vaccinating an animal NI against infection by a Brucella organism, including methods of distinguishing between a vaccinated and an infected animal. There are further provided novel methods of detecting the presence in a sample of an anti-Brucella antibody.
A molecule comprising a chain of seven or more contiguous units of 4,6-dideoxy-4-formamido-α-mannopyranose, adjacent units being joined by a C1-C2 or a C1-C3 link, the chain having a terminal end and a reducing end, wherein the pyranose ring in the unit of the chain most distal from the reducing end is linked to a cap structure, with the proviso that the cap structure is not a 4,6-dideoxy-4-acylamido-α-D-mannopyranose or a 4,6-dideoxy-4-acylamido-α-D-glucopyranose linked to the remainder of the molecule via its C1.
A molecule comprising a chain of seven or more contiguous units of 4,6-dideoxy-4-formamido-α-mannopyranose, adjacent units being joined by a C1-C2 or a C1-C3 link, the chain having a terminal end and a reducing end, wherein the pyranose ring in the unit of the chain most distal from the reducing end is linked to a cap structure, wherein the cap structure comprises Formula 4:
A molecule comprising a chain of seven or more contiguous units of 4,6-dideoxy-4-formamido-α-mannopyranose, adjacent units being joined by a C1-C2 or a C1-C3 link, the chain having a terminal end and a reducing end, wherein the pyranose ring in the unit of the chain most distal from the reducing end is linked to a cap structure, wherein the cap structure consists of Formula 2:
Dependencies are inferred from the claim text.